Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000203826 | SCV000260828 | benign | Long QT syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000252905 | SCV000319114 | benign | Cardiovascular phenotype | 2016-02-02 | criteria provided, single submitter | clinical testing | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance |
Ambry Genetics | RCV000715597 | SCV000846426 | benign | History of neurodevelopmental disorder | 2016-02-02 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001193294 | SCV001362031 | benign | not specified | 2019-07-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001689734 | SCV001915513 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001689734 | SCV004563002 | benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing |